Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer

Breast cancer is genetically and clinically heterogeneous, which makes it challenging to identify effective patient-specific therapies. Although mortality due to breast cancer in the United States has decreased, more than 40,000 women in the United States still die from this disease each year.…

from Cancer via ola Kala on Inoreader http://ift.tt/29jJcBP
via IFTTT